Cargando…

Correction: Hyperleptinemia in children with autosomal recessive spinal muscular atrophy type I-III

Detalles Bibliográficos
Autores principales:	Kölbel, Heike, Hauffa, Berthold P., Wudy, Stefan A., Bouikidis, Anastasios, Della Marina, Adela, Schara, Ulrike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383331/ https://www.ncbi.nlm.nih.gov/pubmed/28384258 http://dx.doi.org/10.1371/journal.pone.0175611

Ejemplares similares

Hyperleptinemia in children with autosomal recessive spinal muscular atrophy type I-III
por: Kölbel, Heike, et al.
Publicado: (2017)

Editorial: Spinal Muscular Atrophy: Evolutions and Revolutions of Modern Therapy
por: Finkel, Richard S., et al.
Publicado: (2020)

Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years
por: Vill, Katharina, et al.
Publicado: (2021)

Exome reanalysis and proteomic profiling identified TRIP4 as a novel cause of cerebellar hypoplasia and spinal muscular atrophy (PCH1)
por: Töpf, Ana, et al.
Publicado: (2021)

High-sensitive cardiac troponin I (hs-cTnI) concentrations in newborns diagnosed with spinal muscular atrophy
por: Johannsen, Jessika, et al.
Publicado: (2023)

Infants Diagnosed with Spinal Muscular Atrophy and 4 SMN2 Copies through Newborn Screening – Opportunity or Burden?(1)
por: Müller-Felber, Wolfgang, et al.
Publicado: (2020)

Spinal astrocyte dysfunction drives motor neuron loss in late-onset spinal muscular atrophy
por: Schmitt, Linda-Isabell, et al.
Publicado: (2023)

Tremor in X-linked recessive spinal and bulbar muscular atrophy (Kennedy's disease)
por: Dias, Francisco A, et al.
Publicado: (2011)

Muscular and Molecular Pathology Associated with SPATA5 Deficiency in a Child with EHLMRS
por: Braun, Frederik, et al.
Publicado: (2021)

Long Term Follow-Up on Pediatric Cases With Congenital Myasthenic Syndromes—A Retrospective Single Centre Cohort Study
por: Della Marina, Adela, et al.
Publicado: (2020)

Autosomal recessive limb-girdle muscular dystrophies in the Czech Republic
por: Stehlíková, Kristýna, et al.
Publicado: (2014)

Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011)

Autosomal recessive pathogenic MSTO1 variants in hereditary optic atrophy
por: Gerber, Sylvie, et al.
Publicado: (2023)

Nusinersen in pediatric and adult patients with type III spinal muscular atrophy
por: Pera, Maria Carmela, et al.
Publicado: (2021)

Hyperleptinemia Is Required for the Development of Leptin Resistance
por: Knight, Zachary A., et al.
Publicado: (2010)

SMArtCARE - A platform to collect real-life outcome data of patients with spinal muscular atrophy
por: Pechmann, Astrid, et al.
Publicado: (2019)

Nusinersen for spinal muscular atrophy
por: Wurster, Claudia D., et al.
Publicado: (2018)

Spinal Muscular Atrophy and Ependymoma
por: Albakr, Aishah, et al.
Publicado: (2017)

Risdiplam for spinal muscular atrophy
Publicado: (2022)

GLS loss of function causes autosomal recessive spastic ataxia and optic atrophy
por: Lynch, David S., et al.
Publicado: (2018)

Robust genotyping tool for autosomal recessive type of limb-girdle muscular dystrophies
por: Inashkina, Inna, et al.
Publicado: (2016)

Longitudinal characterization of biomarkers for spinal muscular atrophy
por: Bonati, Ulrike, et al.
Publicado: (2017)

TMEM126A mutation in a Moroccan family with autosomal recessive optic atrophy
por: Désir, Julie, et al.
Publicado: (2012)

Feasibility of Using Microsoft Kinect to Assess Upper Limb Movement in Type III Spinal Muscular Atrophy Patients
por: Chen, Xing, et al.
Publicado: (2017)

Modeling Spinal Muscular Atrophy in Drosophila
por: Chang, Howard Chia-Hao, et al.
Publicado: (2008)

Carrier screening for spinal muscular atrophy
por: Prior, Thomas W.
Publicado: (2008)

Androgens in spinal and bulbar muscular atrophy
Publicado: (2012)

Spinal Muscular Atrophy: The Treatment Approved
por: Tabet, Rabih, et al.
Publicado: (2017)

Advances in spinal muscular atrophy therapeutics
por: Parente, Valeria, et al.
Publicado: (2018)

Euglycemic Ketoacidosis in Spinal Muscular Atrophy
por: Stoimenis, Dimitrios, et al.
Publicado: (2019)

Metabolic Dysfunction in Spinal Muscular Atrophy
por: Deguise, Marc-Olivier, et al.
Publicado: (2021)

Update on Biomarkers in Spinal Muscular Atrophy
por: Pino, Megan G, et al.
Publicado: (2021)

Onasemnogene abeparvovec for spinal muscular atrophy
Publicado: (2022)

Mitochondrial Dysfunction in Spinal Muscular Atrophy
por: Zilio, Eleonora, et al.
Publicado: (2022)

Editorial: Advances in spinal muscular atrophy
por: Sun, Jianli
Publicado: (2023)

Essen transition model for neuromuscular diseases
por: Fleischer, Michael, et al.
Publicado: (2022)

„Essener Transitionsmodell“ bei neuromuskulären Erkrankungen
por: Fleischer, Michael, et al.
Publicado: (2022)

Vibration-Assisted Home Training Program for Children With Spinal Muscular Atrophy
por: Stark, Christina, et al.
Publicado: (2018)

Nonsense mutation in TMEM126A causing autosomal recessive optic atrophy and auditory neuropathy
por: Meyer, Esther, et al.
Publicado: (2010)

Autosomal Recessive Cerebellar Atrophy and Spastic Ataxia in Patients With Pathogenic Biallelic Variants in GEMIN5
por: Rajan, Deepa S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rnri4c4s6jtr9av9mqs0v02rlr